Mestag Therapeutics
PrivateLast Round
VC Round
Mar 17, 2026
Total Funding Raised
$46.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mestag Therapeutics is a biotechnology company that develops first-in-class immunotherapies targeting fibroblast-immune interactions to treat cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mestag Therapeutics Comparables
Compare Mestag Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Macomics | 77% | |
| Agni Bio, Inc. | 77% | |
| F-star Therapeutics | 77% |
Mestag Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 17, 2026 | ||||
| Grant | Aug 28, 2024 | ||||
| Seed | Aug 3, 2021 |
Key People
Founding team and executive leadership
Mestag Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | VC Round |
| SV Health Investors | VC Round, Seed |
| GV | VC Round, Seed |
| Forbion | VC Round, Seed |
| Northpond Ventures | VC Round, Seed |
| Johnson & Johnson Innovation - JJDC | VC Round |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
$40M raised in early funding.
- Aug 28, 2024
Secured $2M in grant funding from Innovate UK.
Mestag Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mestag Therapeutics's valuation, stock price, and market status.
Is Mestag Therapeutics a public or private company?
Mestag Therapeutics is a private company.
What is the current stock price of Mestag Therapeutics?
Mestag Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Mestag Therapeutics worth (valuation)?
Valuation information for Mestag Therapeutics is not publicly available.
Can I buy Mestag Therapeutics stock?
Mestag Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mestag Therapeutics's last funding round?
Mestag Therapeutics's most recent funding round was Early Funding on March 17, 2026.
Who are the main investors in Mestag Therapeutics?
Key investors in Mestag Therapeutics include Johnson & Johnson Innovation - JJDC.
Will Mestag Therapeutics IPO soon?
No public IPO plans have been announced for Mestag Therapeutics.
How can I track Mestag Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mestag Therapeutics's secondary market activity and sign up for updates.